Jay Moorin

Affiliations

  • Large Shareholder at Urogen Pharma Ltd. (URGN), 2017-11-29
  • Large Shareholder at Eagle Pharmaceuticals Inc. (EGRX), 2017-05-15
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-01-29
  • Director at Arno Therapeutics Inc (ARNI), 2016-01-14
  • Large Shareholder at Immune Design Corp. (IMDZ), 2015-05-13
  • Director at Pegasi Energy Resources Corporation. (PGSI), 2015-01-21
  • Large Shareholder at Novadel Pharma Inc (NVDL), 2012-02-13
  • Large Shareholder at Achillion Pharmaceuticals Inc (ACHN), 2009-12-18
  • Large Shareholder at Avanir Pharmaceuticals Inc. (AVNR), 2009-10-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AGRX $6.35 393,700 $2,499,995.00 5,062,363 2016-01-27 Filing
AGRX $5.85 811,966 $4,750,001.10 4,668,663 2015-01-23 Filing
AGRX $6.00 1,120,833 $6,724,998.00 3,856,697 2014-05-29 Filing
EGRX $15.00 333,333 $4,999,995.00 4,770,828 2014-02-18 Filing
NVDL $0.17 4,848,485 $800,000.03 34,353,138 2010-03-31 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACHN $3.24 70,000 $227,101.00 2,663,854 2009-12-17 Filing
ACHN $3.52 493,452 $1,737,345.80 2,733,854 2009-12-16 Filing
AVNR $2.23 547,135 $1,220,111.05 7,125,754 2009-10-13 Filing
AVNR $2.12 427,145 $905,547.40 7,672,889 2009-10-12 Filing
AVNR $2.46 804,712 $1,979,591.52 8,100,034 2009-10-09 Filing